SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Triangle Pharmaceuticals (VIRS)
An SI Board Since December 1996
Posts SubjectMarks Bans Symbol
34 5 0 VIRS
Emcee:  DD™ Type:  Unmoderated
Introduction Market Data Compact
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9 Kafka, With this aquisition, VIRS will add yet another potential AIDS drug to Thomas E. Wetherby-7/1/1997
8 More shares out and insiders filing. Today Triangle bought a protease inhibito(no name provided)-7/1/1997
7 F. Jay, It is always good to hear from someone who thinks rationally. Kafka66(no name provided)-6/11/1997
6 Kafka: Isn't it great? Now that Soros owns more, everyone else will have tF. Jay Abella, III-6/11/1997
5 To all: Soros buys more VIRS at a discount. No wonder Soros has such a good (no name provided)-6/9/1997
4 Triangle Pharmaceuticals Reports Preliminary Clinical Results for Anti-HIV DrugDD™-1/17/1997
3 Don - It is on my list of the top IPO performers issued since Oct 1, based on pChris Baker-1/17/1997
2 Chris: It has been in my "master list", but not on my "buy listDD™-1/17/1997
1 Don - I'm noticed stock leap on announcement of progress with HIV drug. DChris Baker-1/17/1997
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News